Establishing Direct-to and from-Patient Clinical Trials (Part 1)
Update: 2024-02-21
Description
Critically ill patients increasingly can participate in life saving and life changing cell & gene therapy clinical trials without having to leave their homes with the Direct- to -Patient and Direct- from -Patient model. So how do you set up these supply chains? How do you mitigate risk? And how do you ensure they’re resilient? Mike Sweeney, QuickSTAT’s Global Head of Strategy for CGT and Direct to Patient products, explains.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
